Sleep & Weight Gain

If you want to stay at a healthy weight, be sure to get enough sleep. A large study shows that sleep may be vitally important for keeping the pounds off. Nurses who are chronically sleep deprived also gain the most weight.

Maternity Hospitals: A Study on Delivery Safety

A new study suggests that your choice of maternity hospital can play a big role in your odds of a safe medical delivery or C-section. Delivery complications have risen in recent years. Larger hospitals that deliver more babies tend to provide better outcomes.

Herd Immunity Statistics: HPV

Scotland's HPV Immunization program reduced cervical cancer in patients who received the vaccine and patients who did not. This was a prime example of herd immunity. When you get vaccinated, you help yourself and your community.

Risk of Hip Fracture with Vitamins B6 & B12 Supplements

A new cohort study links Vitamin B6 and B12 supplements with hip fractures. 75,804 patients were followed and surveyed about nutrition habits. The highest risks were seen in volunteers who took high doses of Vitamin B6 and B12.

Top 3 Benefits of Acupuncture in Menopause

Menopause comes with uncomfortable symptoms that can be difficult to treat for some patients. Patients were randomly selected to receive a standardized acupuncture treatment. Over 6 weeks, patients had significant improvements in their hot flashes, sleep, and sweating.

The Effects of Sexual Violence on Health

A recent study has found that sexual harassment and sexual assault are significantly associated with worse health indicators. Sexual harassment is not only harmful mentally, but also may lead to medical consequences as well, particularly high blood pressure. The CDC continues to find a high prevalence of sexual assault against both men and women.

Olaparib: A New Hope for BRCA Patients with Ovarian Cancer

Advanced Ovarian Cancer has been one of the deadliest forms of cancer for women. Even with surgery and chemotherapy, most patients will quickly relapse. In one of the biggest clinical trials to date for Olaparib and PARP Inhibitors, nearly 60% of patients were still relapse free after 3 years compared to 27% of patients who did not receive the drug.